Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Alvesco for the Therapy of Persistent Asthma With or Without Allergic Component

NCT01147224 is registered in ClinicalTrials.gov with AstraZeneca as lead sponsor.

NCT NCT01147224
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01147224 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Alvesco for the Therapy of Persistent Asthma With or Without Allergic Component
Lead sponsor
AstraZeneca
Phase
Observational
Overall status
Completed
Start date
March 31, 2010
Completion date
August 31, 2011
Enrollment
400 (estimated)
Sites
79

Conditions

As the registry lists them; a condition with its own page is linked.

allergy, asthma